PD-L1/PD-1 interaction dysregulates T-cell activity, inducing exhaustion, apoptosis, neutralization, and promoting the production of IL-10, which in turn reduces cytotoxic T-cell (CD8+) activity, promoting cancer development and progression by enhancing tumor cell proliferation and survival (172). The gene discussed is PDCD1; the disease is cancer.